Premium
Role of early definitive management for newly diagnosed malignant pleural effusion related to lung cancer
Author(s) -
Chiang KaYan,
Ho James ChungMan,
Chong Peony,
Tam Terence ChiChun,
Lam David ChiLeung,
Ip Mary SauMan,
Lee YunChor Gary,
Lui Macy MeiSze
Publication year - 2020
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13812
Subject(s) - medicine , lung cancer , malignant pleural effusion , pleurodesis , cancer , hazard ratio , pleural effusion , targeted therapy , oncology , confidence interval
The availability of efficacious anti‐cancer treatments, including oral targeted therapy, do not obviate the need of definitive measures for MPE in newly diagnosed lung cancer. Both early MPE control measures and cancer treatments are warranted to minimize the need of pleural re‐interventions in the course of malignancy. See related Editorial